Pharmacovigilance notifications

SIFI Group has a Vigilance system that allows us to take full responsibility for our medical and non medical products, both marketed or in clinical development and to take appropriate actions, if and when needed, in order to evaluate and update all information regarding the benefit-risk of our products.

 

 
Subject of the inquiry*
E-MAIL*
Description of the inquiry
Informativa sulla privacy

I confirm that I have read the privacy statement and on the basis of that:


Confirmation Code* :

 
 

 
 
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

On our Social Channels

From our News Center

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, and SIFI S.p.A. (“SIFI”), a prominent Italian Eye Care company, today...
 

 

20 September

As of today Fabrizio Folco assumes management of the company's organization for the Italian market SIFI, Italian leader in the development and marketing of innovative...
Follow Us!